CStone Pharmaceuticals

Country
China (Mainland)
Sector
Healthcare
Industry
Biotechnology
Employees
135
Ticker
2616
Exchange
HONG KONG EXCHANGES AND CLEARING LTD
Description
CStone Pharmaceuticals is a biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative oncology therapies. It primarily focuses on developing groundbreaking...

CStone Pharmaceuticals's GHG Emissions Data Preview

In 2023, CStone Pharmaceuticals completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, CStone Pharmaceuticals has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2023202220212020 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
0000000
Download CStone Pharmaceuticals's GHG Emissions data for free

Create your Tracenable account today and download up to 5 company datasets of your choice for free. No credit card required.

Verified Sources Behind CStone Pharmaceuticals’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore CStone Pharmaceuticals’s data sources below and access millions more through our Disclosure Search.

a. CStone Pharmaceuticals's ESG Report 2023
Trace every data point back to CStone Pharmaceuticals’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

b. CStone Pharmaceuticals's ESG Report 2021
Trace every data point back to CStone Pharmaceuticals’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Insights into CStone Pharmaceuticals's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions of CStone Pharmaceuticals amounted to 446.63 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2022, the total operational greenhouse gas (GHG) emissions of CStone Pharmaceuticals decreased by 11.79%, showing that the company has made progress in taking action to reduce the climate impact of its operations. a

CStone Pharmaceuticals's Scope 1 Emissions Over Time

202020212022202301234tCO2e
  • Total Scope 1
  • Year-over-Year Change

What are CStone Pharmaceuticals's Scope 1 emissions?

In 2023, the total Scope 1 emissions of CStone Pharmaceuticals were 0 metric tons of CO₂ equivalent (tCO₂e). a

What are CStone Pharmaceuticals's Scope 2 emissions?

In 2023, CStone Pharmaceuticals reported Scope 2 greenhouse gas (GHG) emissions of 446.63 tCO₂e without specifying the calculation method. a

Has CStone Pharmaceuticals reduced its Scope 2 emissions over time?

Since 2020, CStone Pharmaceuticals's Scope 2 greenhouse gas (GHG) emissions (Unspecified Calculation Method) have remained relatively stable, indicating that CStone Pharmaceuticals 's emissions have plateaued with no significant change in its energy consumption footprint. a b

Compared to the previous year (2022), CStone Pharmaceuticals's Scope 2 emissions (Unspecified Calculation Method) fell by 11.79% in 2023, showing that the company has made progress in taking action to reduce the climate impact of its energy consumption. a

What methodology does CStone Pharmaceuticals use for Scope 2 reporting?

In 2023, CStone Pharmaceuticals reported its Scope 2 emissions using an unspecified methodology. a

CStone Pharmaceuticals's Scope 2 Emissions Over Time

20202021202220230150300450600tCO2e
  • Total Scope 2 (Unspecified Calculation Method)
Want Full Access to CStone Pharmaceuticals's GHG Emissions Dataset?
Sign Up